ARTV
ARTV
NASDAQ · Biotechnology

Artiva Biotherapeutics Inc

$4.01
+0.05 (+1.26%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +103.0% upside
Low Target $7.28
Average Target $8.14
High Target $10.62
Current Price $4.01
Current
$4.01
Target
$8.14
$7.28 $8.14 avg $10.62
Scenario Analysis
Bear Case
$7.28
81.5%
Low target
Base Case
$8.14
+103.0%
Avg target
Bull Case
$10.62
+164.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$14.53
-72.4% from high
52-Week Low
$2.96
+35.5% from low
Target vs 52W High
$8.14
-44.0% vs high
Next Earnings Report
Nov 18, 2026
1d
tomorrow
EPS Est: $-0.56
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.3%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.3%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -31.8%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -51.4%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -32.5%